Related Experiment Videos
Bronchial carcinoid with S-100 positive sustentacular cells
M Barbareschi1, S Ferrero, B Frigo
13rd Chair of Morbid Anatomy and Histopathology, School of Medicine, State University of Milan, Italia.
Tumori
|December 31, 1988
Summary
This case report details a rare double bronchial carcinoid tumor with nodal metastasis and Cushing syndrome. The tumor featured two distinct cell types, including S-100 positive cells, suggesting a unique tumor subtype.
Area of Science:
- Pulmonology
- Oncology
- Surgical Pathology
Background:
- Bronchial carcinoid tumors are neuroendocrine neoplasms of the lung.
- Typical carcinoids represent the most common subtype and generally have a good prognosis.
- Paraneoplastic syndromes, such as Cushing syndrome, can occur secondary to bronchial carcinoid tumors.
Purpose of the Study:
- To report a unique case of a double bronchial carcinoid tumor.
- To investigate the histopathological features of the tumor, including the presence of S-100 positive cells.
- To discuss the potential implications of these findings for tumor classification and clinical management.
Main Methods:
- Histopathological examination of the primary tumor and nodal metastasis.
- Immunohistochemical staining for neuroendocrine markers (argyrophilia, PHE-5) and S-100 protein.
- Electron microscopy to identify neurosecretory granules.
Main Results:
- The bronchial carcinoid tumor exhibited a double cell population: argyrophilic, PHE-5 positive cells with neurosecretory granules, and S-100 positive stellate cells.
- The S-100 positive cells were located at the periphery of the nests of the other cells, suggesting a sustentacular or satellite role.
- The tumor presented with nodal metastasis and paraneoplastic Cushing syndrome.
Conclusions:
- Bronchial carcinoids with S-100 positive cells may represent a distinct subgroup with potentially different histogenesis or differentiation.
- The S-100 positive cells are likely neoplastic and may function as sustentacular cells.
- Further research is needed to determine the clinical significance and prognostic implications of S-100 positive cells in bronchial carcinoids.